The risk of tuberculosis in patients treated with TNF antagonists - PubMed (original) (raw)
Review
The risk of tuberculosis in patients treated with TNF antagonists
Eva Salgado et al. Expert Rev Clin Immunol. 2011 May.
Abstract
Over the last 12 years, TNF antagonists have been successfully used for the treatment of numerous patients afflicted by chronic inflammatory disorders. However, data from clinical trials and registries have shown that patients treated with these biologics have an increased risk of reactivating latent TB. The fact that TNF plays a role in the immune cell response and, more specifically, in maintenance of granuloma integrity is the accepted grounds for reactivation of TB following inhibition of TNF. Appropriate screening of latent TB and proper management of cases substantially reduces the incidence of active TB. Nevertheless, debate still remains regarding the value of the tuberculin skin test and IFN-γ-release assays as diagnostic tools, and treatment across guidelines and recommendations. This largely reflects differences in background population.
Similar articles
- Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M; BIOBADASER Group. Carmona L, et al. Arthritis Rheum. 2005 Jun;52(6):1766-72. doi: 10.1002/art.21043. Arthritis Rheum. 2005. PMID: 15934089 - Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
Amerio P, Amoruso G, Bardazzi F, Campanati A, Cassano N, Conti A, Gisondi P, Guarneri C, Mazzotta A, Piaserico S, Prestinari F, Prignano F, Zane C, de Simone C. Amerio P, et al. J Dermatolog Treat. 2013 Aug;24(4):305-11. doi: 10.3109/09546634.2011.654107. Epub 2012 Jan 31. J Dermatolog Treat. 2013. PMID: 22208431 - Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group. Hamdi H, et al. Arthritis Res Ther. 2006;8(4):R114. doi: 10.1186/ar1994. Arthritis Res Ther. 2006. PMID: 16859506 Free PMC article. - Certolizumab pegol and rheumatoid arthritis. Just another TNF alpha antagonist, no therapeutic advantage.
[No authors listed] [No authors listed] Prescrire Int. 2010 Dec;19(111):279. Prescrire Int. 2010. PMID: 21355379
Cited by
- The effectiveness and safety of Chinese medicines for the treatment of uveitis: A protocol for systematic review and meta-analysis.
Han M, Chen Y, Nong L, Liu Z, Qin Y, Meng H, Chen Y, Wang Z, Jin M. Han M, et al. Medicine (Baltimore). 2020 Jun 26;99(26):e20766. doi: 10.1097/MD.0000000000020766. Medicine (Baltimore). 2020. PMID: 32590753 Free PMC article. - Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis.
Maiga M, Ahidjo BA, Maiga MC, Cheung L, Pelly S, Lun S, Bougoudogo F, Bishai WR. Maiga M, et al. EBioMedicine. 2015 Jul 14;2(8):868-73. doi: 10.1016/j.ebiom.2015.07.014. eCollection 2015 Aug. EBioMedicine. 2015. PMID: 26425693 Free PMC article. - [Guidelines for vaccination of immunocompromised individuals].
Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, Kitchen M, Köller M, Kollaritsch H, Kundi M, Lassmann H, Mutz I, Pickl WF, Riedl E, Sibilia M, Thalhammer F, Tucek B, Zenz W, Zwiauer K. Wiedermann U, et al. Wien Klin Wochenschr. 2016 Aug;128 Suppl 4:337-76. doi: 10.1007/s00508-016-1033-6. Epub 2016 Jul 25. Wien Klin Wochenschr. 2016. PMID: 27457874 German. - Lethal disseminated tuberculosis in patients under biological treatment - two clinical cases and a short review.
Dantes E, Tofolean DE, Fildan AP, Craciun L, Dumea E, Tofolean IT, Mazilu L. Dantes E, et al. J Int Med Res. 2018 Jul;46(7):2961-2969. doi: 10.1177/0300060518771273. Epub 2018 May 23. J Int Med Res. 2018. PMID: 29792084 Free PMC article. Review. - An Investigation into the Immunomodulatory Activities of Sutherlandia frutescens in Healthy Mice.
Lei W, Browning JD Jr, Eichen PA, Folk WR, Sun GY, Lubahn DB, Fritsche KL. Lei W, et al. PLoS One. 2016 Aug 30;11(8):e0160994. doi: 10.1371/journal.pone.0160994. eCollection 2016. PLoS One. 2016. PMID: 27575007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical